Mouse Hybridoma Clone 2C6 Against Human Connexin 43 (Unphosphorylated and pS368; 2C6 Hybridoma; TID 21-004)

Researchers at Fred Hutchinson Cancer Center have developed a hybridoma cell line that expresses mouse anti-human Connexin 43 (recognizes unphosphorylated and phospho-S368) antibodies. This monoclonal antibody has been validated for use with western blotting as shown in the image.

CHO cells either untreated or treated with TPA to increase phosphorylation on Cx43 at serine 368.
CHO cells either untreated or treated with TPA to increase phosphorylation on Cx43 at serine 368. When Cx43 is phosphorylated, migration is SDS-AGE is slowed in the left panel. In the right panel, the phosphorylation is shown to be increased.

Available Licenses

To license this product, please complete, sign and return the license agreement to bds@fredhutch.org. Further instructions are provided therein.

Please Note: Academic and non-profit users may license the material for free. Fees for for-profit users are listed in the license agreements. All recipients must pay a fee for material preparation and shipping expenses.

Download license agreement
Commerical Use | Non-commerical Use

Credit line for acknowledgement

When publishing on the use of this material, please provide credit to Dr. Paul Lampe according to accepted publications standards.

Questions About this Product?

Contact the Business Development team

Phone: 206.667.4304